MTOR and neoplasm: Meanwhile, some counter-regulatory mechanisms exist, such as miR-206 and miR-99b, that mediate the transition of TAMs back to an M1 state by activating NF-κB and suppressing mTOR/IRF4, enhancing CD8+ T-cell recruitment and tumor phagocytosis [39,40].